Retina-Vitreous
2022 , Vol 31 , Num 3
A Rare Differential Diagnosis of Neovascular Age-Related Macular Degeneration: Choroidal Metastasis
Ophthalmologist, Sultan Abdülhamid Training and Research Hospital, Ophthalmology Department, İstanbul Turkey
DOI :
10.37845/ret.vit.2022.31.50
We present the case of 80-year-old patient with choroidal metastasis that was initially misdiagnosed as neovascular age-related macular
degeneration (n-AMD) because of the presence of subretinal fluid. He received four intravitreal ranibizumab injections within six months
before he was referred to our retina clinic due to unresponsiveness. A clinical diagnosis of choroidal metastasis from an advanced pulmonary
adenocarcinoma was made with an interdisciplinary approach. Three doses of intravitreal aflibercept (AFL) were administered with 9
concurrent cycles of systemic chemotherapy over 13 months. Visual acuity improved from 20/125 to 20/63; complete resolution of the mass
was obtained with residual pigmentary and atrophic changes. This regression was sustained during follow-up period, even though the systemic
disease progressed. This is the first report of successful combination therapy of intravitreal AFL and systemic chemotherapy. Despite being
rare, choroidal metastasis should be considered as a differential diagnosis of n-AMD.
Keywords :
Aflibercept, choroidal metastasis, drug therapy; combination, non-small-cell lung cancer